| 1 |
34877660 | Effect of CYP3A5 and CYP3A4 Genetic Variants on Fentanyl Pharmacokinetics in a Pediatric Population. | 2022 Apr |
4 |
| 2 |
27619152 | A review of factors explaining variability in fentanyl pharmacokinetics; focus on implications for cancer patients. | 2017 Feb |
1 |
| 3 |
27236640 | Relationship between the plasma fentanyl and serum 4β-hydroxycholesterol based on CYP3A5 genotype and gender in patients with cancer pain. | 2016 Jun |
4 |
| 4 |
25832841 | [Clinical pharmacology and pharmacoepidemiology for medication safety in clinical settings]. | 2015 |
1 |
| 5 |
24365989 | Impact of CYP3A5*3 on plasma exposure and urinary excretion of fentanyl and norfentanyl in the early postsurgical period. | 2014 Jun |
2 |
| 6 |
24469018 | Genetic, pathological and physiological determinants of transdermal fentanyl pharmacokinetics in 620 cancer patients of the EPOS study. | 2014 Apr |
1 |
| 7 |
23557865 | Effects of genetic polymorphisms of OPRM1, ABCB1, CYP3A4/5 on postoperative fentanyl consumption in Korean gynecologic patients. | 2013 May |
1 |
| 8 |
22277678 | Impact of CYP3A5 and ABCB1 gene polymorphisms on fentanyl pharmacokinetics and clinical responses in cancer patients undergoing conversion to a transdermal system. | 2012 |
4 |
| 9 |
21513075 | Influence of CYP3A5*3 polymorphism and interaction between CYP3A5*3 and CYP3A4*1G polymorphisms on post-operative fentanyl analgesia in Chinese patients undergoing gynaecological surgery. | 2011 Apr |
8 |
| 10 |
16419387 | Pharmacogenomics as molecular autopsy for forensic toxicology: genotyping cytochrome P450 3A4*1B and 3A5*3 for 25 fentanyl cases. | 2005 Oct |
5 |